Registered entities
SCIPHER MEDICINE
Reg. No. 463927710Belgium
Innovation
11 patent families (3 granted) — focus: Physics & computing, Chemistry & metallurgy, Human necessities; filing pace steady. Cited 1,314 times.
| Year | Filings |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 9 |
| 2023 | 4 |
| 2024 | 8 |
| 2025 | 5 |
| 2026 | 4 |
Social engagement
Social engagement: 30K social following, 8 posts in the last 12 months — below the industry typical range.
Investor mix
16 investors on record; lead investors include Optum Ventures, aMoon, Northpond Ventures, Khosla Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 44% |
| Private equity | 3 | 19% |
| Accelerator & incubator | 1 | 6% |
| Bank & private debt | 2 | 13% |
| Other / undisclosed | 3 | 19% |
Recent activity
10 Mar 2026
Partnership
Senelix
26 Jan 2026
Product launch
SpectraAI
23 Jan 2026
Product launch
PrismRA®